Neal Gilmer is maintaining his “Buy” rating and C$21.00 target price, citing strong margins, robust cash flow and continued ...

Knight Therapeutics is continuing to build momentum, according to Stifel Nicolaus Canada analyst Justin Keywood.

Roth Capital Partners has raised its price target on Groupon ( Groupon Inc Stock Quote, Chart, News, Analysts, Financials ...

Haywood Capital Markets analyst Neal Gilmer says Verano Holdings ( Verano Holdings Stock Quote, Chart, News, Analysts, ...

In his May 7 corporate update, Leung remained bullish on Well Health’s positioning as a consolidator in Canada’s healthcare ...

5N Plus’s quarterly revenue rose 36.7% year over year to $88.9-million, beating both Ventum’s $70.6-million and the Street’s ...

Xtract One Technologies may be nearing a significant financial milestone, with Ventum Capital calling the security tech firm ...

Ballard Power’s disappointing Q1 2025 results prompted Roth Capital Partners analyst Craig Irwin to reaffirm his $1.25 price ...

Spectral is a clinical-stage medical device company focused on developing therapies for critical care, particularly septic ...

ATB Capital Markets is sticking with its bullish view on Bitfarms, maintaining an Outperform rating and a $3.75 price target ...

Ahead of the company’s first quarter results, National Bank Financial analyst Cameron Doerksen has upgraded CAE.

In a May 5 investor note, Leede Financial analyst Douglas Loe reiterated his Speculative Buy rating and $3.00 target for ...